• Profile
Close

Patterns of care and survival impact of adjuvant chemoradiotherapy for oropharyngeal cancer with intermediate-risk features

Head & Neck May 24, 2019

Goel AN, et al. - Survival outcomes in 2164 patients with oropharyngeal squamous cell carcinoma with intermediate-risk features were compared for adjuvant chemoradiotherapy (aCRT) vs adjuvant radiotherapy (aRT). The patients were without positive margins or extracapsular extension and had at least one intermediate-risk feature. For both human papillomavirus (HPV)-positive (62.0%) and HPV-negative (64.3%) patients, aCRT was commonly used but was not associated with better survival vs aRT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay